RN7SL840P

Across TCGA pan-cancer cohorts, RN7SL840P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RN7SL840P data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RN7SL840P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL840P expression acts as an unfavorable survival marker, although some lineages such as PAAD and DLBC show a favorable association.

CESC, ESCA, and ACC are the cancer types where RN7SL840P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Tertile	IV	0.308	0.569	.018	38	view →
ESCA	OS	Quartile	All	0.451	1.000	.010	29	view →
ACC	OS	Tertile	All	0.521	0.905	.008	24	view →
THCA	DFS	Tertile	IV	0.126	0.805	.002	18	view →
PAAD	OS	Tertile	II,III,IV	0.731	0.442	.034	9	view →
LIHC	DFS	Tertile	III,IV	0.094	0.424	.003	9	view →
KIRC	OS	Tertile	All	0.510	0.665	.013	8	view →
LUSC	DFS	Tertile	All	0.258	0.526	.030	6	view →
DLBC	DFS	Tertile	All	1.000	0.515	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RN7SL840P–CESC (DFS)

Open the CESC breakdown →